These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1321101)

  • 21. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiosynthesis of high effective specific-activity [123I]SCH 23982 for dopamine D-1 receptor-based SPECT imaging.
    Moerlein SM; Parkinson D; Welch MJ
    Int J Rad Appl Instrum A; 1990; 41(4):381-5. PubMed ID: 2158956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2- and 4-[18F]fluorotropapride, two specific D2 receptor ligands for positron emission tomography: N.C.A. syntheses and animal studies.
    Damhaut P; Cantineau R; Lemaire C; Plenevaux A; Christiaens L; Guillaume M
    Int J Rad Appl Instrum A; 1992 Oct; 43(10):1265-74. PubMed ID: 1330979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
    Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET.
    Halldin C; Farde L; Högberg T; Hall H; Sedvall G
    Int J Rad Appl Instrum A; 1990; 41(7):669-74. PubMed ID: 2170298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.
    Perlmutter JS; Moerlein SM; Hwang DR; Todd RD
    J Neurosci; 1991 May; 11(5):1381-9. PubMed ID: 1827499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific in vivo binding of 77Br-brombenperidol in rat brain.
    Moerlein SM; Stöcklin G
    Life Sci; 1984 Sep; 35(13):1357-63. PubMed ID: 6482657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (3-N-[11C]methyl)spiperone, a ligand binding to dopamine receptors: radiochemical synthesis and biodistribution studies in mice.
    Burns HD; Dannals RF; Langström B; Ravert HT; Zemyan SE; Duelfer T; Wong DF; Frost JJ; Kuhar MJ; Wagner HN
    J Nucl Med; 1984 Nov; 25(11):1222-7. PubMed ID: 6333496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor.
    Welch MJ; Katzenellenbogen JA; Mathias CJ; Brodack JW; Carlson KE; Chi DY; Dence CS; Kilbourn MR; Perlmutter JS; Raichle ME
    Int J Rad Appl Instrum B; 1988; 15(1):83-97. PubMed ID: 3258305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
    Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.
    Shiue CY; Fowler JS; Wolf AP; Watanabe M; Arnett CD
    J Nucl Med; 1985 Feb; 26(2):181-6. PubMed ID: 2857191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and biological evaluation of 18F-labeled benzamide analogs as potential dopamine D2 receptor ligands.
    Kiesewetter DO; Kawai R; Chelliah M; Owens E; McLellan C; Blasberg RG
    Int J Rad Appl Instrum B; 1990; 17(4):347-56. PubMed ID: 2143753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.
    Nikolaus S; Larisch R; Beu M; Forutan F; Vosberg H; Müller-Gärtner HW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):390-5. PubMed ID: 12634967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol.
    Nikolaus S; Larisch R; Beu M; Vosberg H; Müller-Gärtner HW
    J Nucl Med; 2001 Nov; 42(11):1691-6. PubMed ID: 11696641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer.
    Mukherjee J; Yang ZY; Das MK; Brown T
    Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies.
    Mathis CA; Bishop JE; Gerdes JM; Whitney JM; Brennan KM; Jagust WJ
    Int J Rad Appl Instrum B; 1992 Jul; 19(5):571-88. PubMed ID: 1399687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET).
    Dewey SL; Logan J; Wolf AP; Brodie JD; Angrist B; Fowler JS; Volkow ND
    Synapse; 1991 Apr; 7(4):324-7. PubMed ID: 2042113
    [No Abstract]   [Full Text] [Related]  

  • 40. Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens.
    Kiesewetter DO; Eckelman WC; Cohen RM; Finn RD; Larson SM
    Int J Rad Appl Instrum A; 1986; 37(12):1181-8. PubMed ID: 3028984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.